EUVIMEDEUVIMED entdecken
Crossref

Exploring the Anti‐inflammatory Molecular Mechanism of L‐shikonin in Promoting Diabetic Wound Healing by Modulating the Janus Kinase/Phosphatidylinositol‐3‐kinase/Protein Kinase B/Vascular Endothelial Growth Factor Pathway Based on Network Pharmacology

Kun Li, Yifan Liu, Tiantian Gao, Lijie Pang, Yunpeng Diao, Shuyuan Fan iD

Chemistry & Biodiversity · 2025

DOI: 10.1002/cbdv.202501224 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2025. Verfasst von Kun Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Chemistry and Chemical Engineering, Liaoning Normal University, Dalian, China. Hauptthemen laut MEDLINE: Wound Healing, Diabetes Mellitus, Experimental, Anti-Inflammatory Agents, Diabetic Foot. Die Arbeit nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetic foot ulcers (DFUs) exhibit impaired healing due to disrupted macrophage polarization, wherein persistent hyperglycemia inhibits the critical M1‐to‐M2 phenotypic transition, sustaining a pro‐inflammatory microenvironment. This investigation elucidates the therapeutic potential of L‐shikonin (L‐SK), a bioactive phytochemical derived from comfrey with established immunomodulatory properties. In a streptozotocin‐induced diabetic murine model, L‐SK treatment significantly enhanced wound closure through coordinated anti‐inflammatory effects (downregulation of CD86 and tumor necrosis factor‐α) and pro‐regenerative outcomes (increased collagen deposition and CD31‐mediated angiogenesis). At the molecular level, L‐SK administration facilitated macrophage polarization towards the regenerative M2 phenotype (upregulated CD163 expression) while activating the pivotal Janus Kinase/phosphatidylinositol‐3‐kinase/protein kinase B/vascular endothelial growth factor (JAK/PI3K/AKT/VEGF) signaling cascade, as evidenced by enhanced phosphorylation of AKT and PI3K alongside elevated VEGF production. Complementary in vitro studies using human monocytic leukemia cells‐derived macrophages confirmed these mechanistic findings, demonstrating consistent modulation of macrophage differentiation markers and secretory profiles. These results position L‐SK as a multifaceted therapeutic agent capable of concurrently addressing the immunological and vascular deficiencies characteristic of DFUs, through its dual capacity for macrophage phenotype reprogramming and angiogenic pathway activation. The study provides compelling preclinical evidence for L‐SK's potential application in diabetic wound management strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Wound HealingDiabetes Mellitus, ExperimentalAnti-Inflammatory AgentsDiabetic FootAnimalsMiceHumansProto-Oncogene Proteins c-aktNetwork PharmacologyVascular Endothelial Growth Factor ASignal TransductionPhosphatidylinositol 3-KinasesJanus KinasesMacrophagesPhosphatidylinositol 3-KinaseMaleMice, Inbred C57BL

Stichwörter der Autor:innen

L‐shikoninanti‐inflammatory and proliferativebioactive small molecules from natural sourcesdiabetic foot ulcers

Substanzen

Proto-Oncogene Proteins c-aktVascular Endothelial Growth Factor APhosphatidylinositol 3-KinasesJanus KinasesPhosphatidylinositol 3-KinaseAnti-Inflammatory Agents

Autor:innen und Institutionen

  • College of Chemistry and Chemical Engineering, Liaoning Normal University, Dalian, China.
  • College of Pharmacy, Dalian Medical University, Dalian, China.
  • Dalian Anti-Infective Traditional Chinese Medicine Development Engineering Technology Research Center, China.

ORCID-Profile: Shuyuan Fan

Zitieren

APA

Li, K., Liu, Y., Gao, T., Pang, L., Diao, Y., & Fan, S. (2025). Exploring the Anti‐inflammatory Molecular Mechanism of L‐shikonin in Promoting Diabetic Wound Healing by Modulating the Janus Kinase/Phosphatidylinositol‐3‐kinase/Protein Kinase B/Vascular Endothelial Growth Factor Pathway Based on Network Pharmacology. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202501224

Vancouver

Li K, Liu Y, Gao T, Pang L, Diao Y, Fan S. Exploring the Anti‐inflammatory Molecular Mechanism of L‐shikonin in Promoting Diabetic Wound Healing by Modulating the Janus Kinase/Phosphatidylinositol‐3‐kinase/Protein Kinase B/Vascular Endothelial Growth Factor Pathway Based on Network Pharmacology. Chemistry & Biodiversity. 2025. doi:10.1002/cbdv.202501224

BibTeX
@article{Li2025,
  author = {Li, Kun and Liu, Yifan and Gao, Tiantian and Pang, Lijie and Diao, Yunpeng and Fan, Shuyuan},
  title = {Exploring the Anti‐inflammatory Molecular Mechanism of L‐shikonin in Promoting Diabetic Wound Healing by Modulating the Janus Kinase/Phosphatidylinositol‐3‐kinase/Protein Kinase B/Vascular Endothelial Growth Factor Pathway Based on Network Pharmacology},
  journal = {Chemistry & Biodiversity},
  year = {2025},
  doi = {10.1002/cbdv.202501224}
}
Kostenlos starten →